Users Coming Off Anti-Obesity Medications Put On Weight Far More Rapidly Than Dieters

Fresh analysis suggests that people who stop using new weight-loss injections like semaglutide or tirzepatide tend to recover lost weight at a significantly accelerated pace than those who stop traditional diet and exercise plans.

Published data in a prominent health publication points out that while overweight individuals can lose a large proportion of their total mass while undergoing treatment, the weight returns at an average rate of nearly a kilo each month once they quit.

"People using these treatments should be aware of the danger of rapid weight regain when the therapy ends," stated expert Dr. Susan Jebb.

That rate of recovery means a reversion to starting weight in about a year and a half.

Analyzing Therapies

The research, which looked at dozens of studies involving over 9,000 of participants, contrasted the results of the injectable medications with conventional dieting.

The team point out that people who shed pounds through lifestyle changes alone generally have a slower creep back—around 0.1 kg a month—post-intervention.

The Reason for the Fast Regain

Doctors believe the mechanism of the injections explains the amplified rebound.

GLP-1 drugs mimic a natural hormone called glucagon-like peptide-1, which controls hunger.

"Long-term administration of the hormone levels several times higher than the body's typical production might result in the body to generate a reduced amount of its own natural hormone, and could reduce responsiveness to its effects," noted Dr. Adam Collins, a dietetics researcher.

"Stopping of this GLP-1 'fix' means hunger is uncontrolled, making overeating far more likely."

A Chronic Issue?

Health authorities suggest the injections for people with weight-linked health risks, alongside recommended lifestyle changes.

A number of clinicians say that, given the likelihood of weight regain, the therapy might need to be life-long.

This view is echoed by drug manufacturers, who say that the findings "emphasize the persistent character of excess weight," akin to managing conditions like high blood pressure.

Patient Accounts

Users who have discontinued the medication report a intense resurgence of appetite.

"It was like a trigger activating and you become extremely hungry," said a patient.

This challenge is exacerbated if individuals have not developed sustainable dietary or behavioural modifications during treatment.

Growing Adoption

Recent estimates suggest that a significant number of people in the UK have used weight-loss jabs in the past year, with demand continuing to grow.

• Use is higher among women compared to men.
• The 40s and 50s age group shows the highest level of interest.
• A large proportion access the drugs through private prescriptions rather than public health services.

In conclusion, researchers stress that while these medications are effective agents for weight loss, they are not a magic solution and long-term success likely depends on combined lifestyle changes.